{"name":"Argos Therapeutics","slug":"argos-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQUGR2LTZ6OUtkelJNT2RLSS12bGxFd04wdnQ4UU1fNWtHT1ozYzNoaDY0U0c1T3dZOGNKYktkVVdaaE9scmNWdXJsRnY2ZUMtZ0ROQ1FPZ050M2JMUThILXdmVUVZbjNsSkpPTWJYaU80R254S1BtZTRtZEpxYTFuYg?oc=5","date":"2026-03-24","type":"pipeline","source":"Fast Company","summary":"The most innovative biotech companies of 2026 - Fast Company","headline":"The most innovative biotech companies of 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxOWmdoSVZTdVhrc3VVWXlRWHdpT2l0Y3ZYSDBld0V5VlEwX1lEenNkNlBBMEI0X19WVVYxdGFuOWY3VzlLek5zbXBmVGVZMFFHamp5bFB0dmctLWs2RTRUQVM3eXFlLURMMW1kcUdvUllvUDVqRjJQR3ppRzI0SXRsZExxSGdiSFNaeGJpOGpqXzIwSEFUQ0dxdko5RFBUcWJUdHNzaWFiM2FaQ2lGdlBrVTV2V2RVaXgwRDNuX01ZdmFaQ05PNDZqdjRrT2hYaWxyZFk4d1FNUFdkQTlUYUZEU2sxaGh5ZkQxeTlTQ1dsQm1HQUhnX2JHTWE2Yw?oc=5","date":"2026-03-05","type":"trial","source":"Barchart.com","summary":"Renal Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Barchart.com","headline":"Renal Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Domain | Delve","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxQblVacUhkbHViTXJnZDNta0Q1OXFROUtKazhjU0pXVWI3ZVppSi11YUJtR3hqRkVpTm5sTF9RM1FQX3kwY1RHTlVjMzJJODdIbTJvakk3NFByaUJuNWN6Z1A3S2M4aG52N2RLRDFqeHRfYVEzdWVaMHhkM0tQYUt2cFNFQ1k1RllCaVdQdDVnQl9PdU5ZcnVYVDZCelZNYW5OVEo2TERUZ2FFUHpwMEFrWEJIdTNvdk14RFNKTWhhNVEyMjZDVDFnVFoyOFdEdTJMZjZWWHIzQlVYeWRmSDhzRmlyNHY0Sml1bHVRc3hOT1ozbFp6MGlBWGxpeXdKZENJSS03Uzhma3puRkljVG9YdTFvTTg?oc=5","date":"2026-02-25","type":"trial","source":"prnewswire.com","summary":"Argo Biopharma to Present Positive Phase II Interim Results of siRNA Therapeutic BW-20805 for HAE at the 2026 AAAAI Annual Meeting - prnewswire.com","headline":"Argo Biopharma to Present Positive Phase II Interim Results of siRNA Therapeutic BW-20805 for HAE at the 2026 AAAAI Annu","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPdnhyNTBfbXVDNlFQTnJYUDZsdGxtRDVIVjFDT0EyQ0FmUEFQQ0hXT0RGc3Q1dDl0N3cwNDFZVXljY3lLVERfNV9jOTNBa2dWeVFfSTROeUFObi1uNXJpbTlVZ1NtMklWXzYzUV9PTmhld09CaUlYalhHQzRaX3hXUTBZNkpTekJfUFV5emFOVDBoT1ZEc01JZkY5ZFlTcDZ1cFJYNjNSVFB2NGdXODJpWg?oc=5","date":"2025-09-04","type":"deal","source":"Pharmaceutical Technology","summary":"Novartis adds again to siRNA pipeline with second deal in a day - Pharmaceutical Technology","headline":"Novartis adds again to siRNA pipeline with second deal in a day","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQU2UwYlpISmJHSjE1REhmNmViRTBnUmxtcGFlOFJpV3dtNnRtQ1VKWXJwQkZseGFVbE1DUXkwNFBUVjc3T3BHaFlOdEpic1pfeWZ6N21PZnM0S0hraU54VTVuc3BBT1BjSXpqSUUyLXBqQy1LdHZ6Z0FNaWdRQ3hJVzBFX2tRcDhmWlYweEpUeHBVNjZCVkc0blBVQ3NXSnV2bE5iWnh6UnZ5QQ?oc=5","date":"2025-09-04","type":"deal","source":"worldpharmaceuticals.net","summary":"Argo, Novartis expand collaboration for cardiovascular therapies - worldpharmaceuticals.net","headline":"Argo, Novartis expand collaboration for cardiovascular therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPWEU4ZzBxZUF1LVNUWTQ4NGplVHFDdnlPQ2J2WFVUcEdOcmZzRG5jbHQ2eE9RNjBORGlrWTctQjlia2xpcENvNTFXSWtYWkFDWnNOWWVIeGE3VTgxYy1Dc25ZdFBGRTlSdElLOVB1Uldtei02cDkwWmFJNFhnMUkxMHJaZ1NrT3duenJJWUprYlFLd3JzZkdQdldmY01JR3c?oc=5","date":"2025-09-03","type":"pipeline","source":"Fierce Biotech","summary":"Novartis returns to Argo for multifaceted $5B cardiovascular collab - Fierce Biotech","headline":"Novartis returns to Argo for multifaceted $5B cardiovascular collab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxNUmU3OUctRkVvYWdEbVROYVBDbklxYkZScVd2QzdIcU5iUzZ4b1NwZHcySzhqa0MxU0FrTmNWb3dFcnNUSlRjTXp4WVRyMEU3N2QtamxsaUpKUDloSGpabDlMd3RGM2JvYVpVMWhpa2Q5UnNsQm5lT2dLeDUxN2JPeU03YW9xQ05pS1BhLURFWEpiM2tDcXBxa2JtTHlRZjB5SjlDTWJ6b2c3b0prejF5WmJnZEh4LXZRN3lfVlhxZmIyNURrRmdBMnhSM2pvWWdrQ0I0Y25Cd3JCR0J5X2ZXMG44RDZ1bFU?oc=5","date":"2025-09-03","type":"deal","source":"Reuters","summary":"Novartis signs up to $5.2 billion licensing deal with China's biotech Argo for heart drugs - Reuters","headline":"Novartis signs up to $5.2 billion licensing deal with China's biotech Argo for heart drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOS0owQWlKSjFDU21udVROY0J6RTFScW45U0ZCSUV2UVc4VjJtLVBJcnZoRGItZDY5QlhIWFpJVmJMNFJHMXZyTW14czVzVDJOSGdfM3JjbDE4MEE1emRfUEpGdnRlUzNNSnpGenhvbU5CS2tRRDkzWnhRcVh2ekNOTTczQUt4aXA3bUFrN1lxMmtJSFZzRlZ0Uw?oc=5","date":"2025-09-03","type":"pipeline","source":"BioSpace","summary":"Novartis Doubles Down on Argo Pact With Fresh $5.2B Commitment - BioSpace","headline":"Novartis Doubles Down on Argo Pact With Fresh $5.2B Commitment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxNbWFjN0E1bGtzRmkxOEo0alc0ZVNFY010ZDlUVzhmejUtWmxLUjVQemxlVVE2M0lvX25lZmIzdEtSZTZhblJibTBaYWN1UU1lSUlkcXRMVUFmSVhfQy1Rb0hUZUI1OGx5Z3lwekFLeklPMlg4ZV81aldNUDdPdkFhZk9oS2NNMi10NmgzZmd0T2VXRzRqeUlvTjh3Nk1hT3I4cWpsamZnS21sQnRGTkVjbEZvWEhhZFVMdVZsX1BJNXZnaTRiMkV1TmFHazdBOGdPNWJNQmNQMDU0WS1zdjVsSVB1bHNOOWxuRGxzMmZPM2QtNTUzSGpIVkZldEZGVjFuc1pZVHN3Vm11WmN5S2t3ZWtR?oc=5","date":"2025-09-03","type":"deal","source":"prnewswire.com","summary":"Argo Biopharma Announces Multi-Asset License and Option Agreements with Novartis for Novel Molecules for Cardiovascular Diseases - prnewswire.com","headline":"Argo Biopharma Announces Multi-Asset License and Option Agreements with Novartis for Novel Molecules for Cardiovascular ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNMjhabXRyS3cybG42MXdOTkNXd1J4QXVYRGZKMkFjR3RUUUh2YnhUNzZYV24xWmkzZXI1ZjFCUzRFaUpmZFVTWHBMUHhlQ0ZNZVI2cXhzUmFtWU9idnZiMHI1NzY5WnNZX0VOaFZGVEtibm1jcDJFdkFZLVE2QURsSkc0M04waFVGT3FWSFVqS3lIZHc?oc=5","date":"2025-09-03","type":"deal","source":"BioPharma Dive","summary":"Novartis licenses RNA drugs in deal with China-based Argo - BioPharma Dive","headline":"Novartis licenses RNA drugs in deal with China-based Argo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPN2xNUk1kb0tXbFBtZ0hCb29hWkFTRjdfUFlKSWtncU0tWHlPTzcxY2VkdnBBcS1FMUw2QnlsaXVHWUR3ZENhYV9DSnZEWjY0bTNjQ096akI1R3pMdnFCam9oNmczV3ZpX2tzaDNCZ2o5VHZoOVZoTy1laUlpZzloY3BVN09xQnM?oc=5","date":"2025-09-03","type":"deal","source":"pharmaphorum","summary":"Novartis pens $5.2bn cardiovascular partnership with Argo - pharmaphorum","headline":"Novartis pens $5.2bn cardiovascular partnership with Argo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAJBVV95cUxQV3p0WXY5ZXdmOG1nQ0hYMFQyVWs2SDhvWjZYNm1XOGRBLXNPdzEtWGo5WTJvSVVRVi1icS05U1hQcUhGRGxGQWxxdF9qejJuWm1BYlRJT2dYaEVmTzkyclRQWllNSmVMSEZheW9TREtoQ05vTzUxQkdSSXE2UFFJOXNHSkNIU0RhU0szNVVTX1FIRU4zU1RLeWh6Q2d1LVZqRmIxNlJUZWFvSWplYWlWTjJoTW5DdnFYXy1Zc01QQzNiZmxSWVRjWU1ZQnFieE1sbDFwZG9JVGhOOVhZelpWM0ZMMXluU2VrdDBEVDliV0RyRmhZblVDREpvVkRhWGdhZTROUWZFaVlhM3FOWWJuRDZXemRkd21Tc2RDOEsxR3BHcW1saEItV1ZvUkxDendudDZBZHFwUlNCRzc2NVBCYmdrMzc?oc=5","date":"2025-08-28","type":"trial","source":"GlobeNewswire","summary":"Antisense Oligonucleotide Therapeutics Clinical Trial - GlobeNewswire","headline":"Antisense Oligonucleotide Therapeutics Clinical Trial","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}